Atlas Trials

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

Clinical trial NCT05556824 · COMPLETED

Trial details

NCT number
NCT05556824
Sponsor
Microbiome Health Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux
Start date
2023-03-03
Primary completion
2026-05-27
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.